Trial Pharmaceutical Substances

The Consortium team is pleased to share that users now may benefit from a trial access to Thieme Pharmaceutical Substances. The trial will expire on 31 December 2021. Pharmaceutical Substances is designed to be a complete reference guide to every pharmaceutical compound of significance. It provides a compendium of some 2,500 active pharmaceutical ingredients (API’s), making it … Continue reading Trial Pharmaceutical Substances